Found 4022 clinical trials
PRB244-01: Treatment of Pruritus in Adults With a History of Atopic Dermatitis
This is a double-blind, randomized, vehicle-controlled study to assess the efficacy, safety, and tolerability of 2 doses of B244 for the treatment of pruritus in adults with a history of
- 0 views
- 29 Apr, 2021
- 1 location
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
This study will assess the safety and efficacy of ARQ-151 cream vs vehicle applied once a day for 4 weeks by subjects with atopic dermatitis (eczema).
- 0 views
- 13 Apr, 2021
- 1 location
Study to Evaluate the Safety Tolerability and Efficacy of BGE-175 in Participants 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants 60 years of age hospitalized with documented COVID-19.
- 0 views
- 29 Mar, 2021
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
- 2068 views
- 23 Nov, 2020
- 22 locations
A Randomized, Double-Blind, Placebo-Controlled Study of COR388 HCl in Subjects with Alzheimer’s Disease
This is a randomized, double-blind, placebo-controlled study that will assess the efficacy, safety, and tolerability of 2 dose levels of COR388 HCl in subjects with probable
- 43 views
- 08 Dec, 2020
- 1 location
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder
The primary objective of the study is to evaluate the efficacy of troriluzole compared to placebo after 8-weeks of treatment in subjects with GAD, as measured by the Hamilton Anxiety Rating Scale (HAM-A) scale
- 383 views
- 10 May, 2019
- 1 location
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
- 9156 views
- 15 Dec, 2020
- 15 locations
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
office visits at the study center. Biohaven is also sponsoring a 48-week open-label extension available for those who complete the double-blind portion.
- 0 views
- 05 Apr, 2021
- 1 location
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
- 52 views
- 23 Nov, 2020
- 1 location
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension period.
- 44 views
- 23 Nov, 2020
- 5 locations